Refine by
Clinical Validation Equipment Supplied In Usa
162 equipment items found
by:Vaxxas, Inc. based inCambridge, MASSACHUSETTS (USA)
Vaxxas is commercializing a novel vaccination technology that dramatically enhances the performance of existing and next-generation vaccines. The core of Vaxxas technology platform is a High Density Microarray Patch (HD-MAP). Vaxxas' HD-MAP is readily fabricated by injection molding to produce small patches each with thousands of very short (~0.25mm) microprojections. Vaxxas has developed novel ...
Manufactured by:Nanovis based inColumbia City, INDIANA (USA)
nanoVIS Ti Surface Technology, applicable to CP Ti and Ti alloy, is a bioceramic bonegrowth nanotube surface specifically designed to increase and accelerate biologic ...
by:Castle Biosciences, Inc. based inFriendswood, TEXAS (USA)
Uveal melanoma, commonly known as ocular or choroidal melanoma, is a rare cancer of the eye with approximately 2,000 patients diagnosed annually in the U.S. At the time of initial diagnosis, approximately 97% of patients are free of metastasis. However, within five years, approximately 30% of patients will develop metastasis – rising to nearly 50% in the following ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Designed to deliver critical information to guide chemotherapy decision-making, Immunoscore® can be used in Stage II localized colon cancer to help physicians identify patients who may be spared adjuvant chemotherapy, and in Stage III localized colon cancer to inform them about the optimal treatment duration for their patients. ...
Manufactured by:Exosome Diagnostics, Inc. based inWaltham, MASSACHUSETTS (USA)
The only exosome-based test that provides unique, actionable intelligence to help you decide if biopsy is necessary; independent of PSA and other standard of care (SOC) features. Connect with a representative in your area for more information today. ...
Manufactured by:AliveCor, Inc based inMountain View, CALIFORNIA (USA)
The world’s only 6-lead personal EKG. Clinically validated to give you a more detailed view of your ...
by:Click Therapeutics, Inc based inNew York, NEW YORK (USA)
CT-132 is under development as a clinically-validated digital program for ...
by:Click Therapeutics, Inc based inNew York, NEW YORK (USA)
Clickadian is under development as a clinically-validated fully digital program for ...
by:Click Therapeutics, Inc based inNew York, NEW YORK (USA)
Clickheart is under development as a clinically-validated digital program for acute coronary ...
by:Click Therapeutics, Inc based inNew York, NEW YORK (USA)
CT-161 is under development as a clinically-validated digital program for overactive ...
by:Qardio, Inc. based inSan Francisco, CALIFORNIA (USA)
Track and manage COVID-19 symptoms over time. QardioSpO2 is a clinically validated pulse oximeter that measures the blood oxygen saturation levels (SpO2) and pulse rate of the body via the fingertip sensor. Compatible with iOS and Android devices. ...
Manufactured by:CytomX Therapeutics, Inc. based inSouth San Francisco, CALIFORNIA (USA)
Bristol Myers Squibb is enrolling patients in the dose escalation phase of a Phase 1/2a clinical trial (NCT03994601) of a second anti-CTLA-4 Probody, BMS-986288, based on a modified version of Yervoy® (ipilimumab), to evaluate a CTLA-4-directed Probody therapeutic alone or in combination with Opdivo® (nivolumab) in patients with selected advanced solid cancers. CTLA-4, a ...
Manufactured by:BridgeBio Pharma, Inc. based inPalo Alto, CALIFORNIA (USA)
In PH1, loss of function mutation in the AGXT gene results in accumulation of glyoxylate, which is converted into oxalate and leads to kidney stones and organ damage. Targeting GO is a clinically validated approach to reduce urinary oxalate by lowering the concentration of glyoxylate. The first-in-human Phase 1 trial of BBP-711 for hyperoxaluria was initiated in ...
by:Vigilant Biosciences, Inc. based inAustin, TEXAS (USA)
Vigilant Biosciences® product is based on advanced patented technology, including an innovative methodology for assessing multiple biomarkers that, together with other clinical factors, can aid clinicians in the early detection of oral cancer. The clinically validated† test contributes to early and accurate† detection of oral ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Immunoscore® for Rectal Cancer can help identify patients with LARC who are at a low risk of relapse and may be good candidates for organ preservation. Immunoscore® is available through an Innovation Access Program while the company conducts clinical validation ...
Manufactured by:Babyscripts based inWashington, DISTRICT OF COLUMBIA (USA)
Lightweight, clinically-validated assessments for prenatal and postpartum mental health that shape better behaviors & drive patient satisfaction. Anxiety, depression, and other maternal mental health issues (MMH) represent the most common complication of pregnancy and childbirth, impacting 800,000 women in the United States each year. ...
Manufactured by:Boston Pharmaceuticals based inCambridge, MASSACHUSETTS (USA)
BOS-475 is a selective BET (bromodomain and extra terminal) inhibitor. BOS-475 potently inhibits multiple clinically validated pathways (IL-12/IL-23-p40, Th17 cytokines and TNF) relevant to psoriasis pathophysiology. BOS-475 demonstrates broad inhibitory activities on other key disease-relevant immune-inflammatory mediators such as MCP-1, IL-6, and CXCL10 & ...
by:Castle Biosciences, Inc. based inFriendswood, TEXAS (USA)
Predicting Individual Risk of Metastasis: DecisionDx-SCC is now commercially available. DecisionDx-SCC is clinically validated as a significant predictor of metastasis and the strongest predictor of risk compared to traditional clinical and pathological factors. DecisionDx-SCC complements traditional prognostic risk assessment factors, enabling ...
Manufactured by:Omron Healthcare, Inc based inHoofddorp, NETHERLANDS
OMRON VIVA is a medical device with clinically validated accuracy of key parameters that allow you to better understand your heart's health (visceral fat, fat and skeletal muscle) and are proven to be predictive for cardiovascular ...
Manufactured by:Great Lakes NeuroTechnologies based inCleveland, OHIO (USA)
The KinesiaU™ motor assessment system serves as a clinically validated, cost-effective prescription application designed for individuals managing Parkinson’s disease and essential tremor. This innovative system is compatible with both iPhone and Android smartphones, as well as smartwatches, allowing users to systematically track core symptoms including tremors, ...